TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Fluorescent Immunoassay Market – By Product Type
1.3.2 North America Fluorescent Immunoassay Market – By Application
1.3.3 North America Fluorescent Immunoassay Market – By End User
1.3.4 North America Fluorescent Immunoassay Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Fluorescent Immunoassay Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinions
5. North America Fluorescent Immunoassay Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Chronic Diseases
5.1.2 Increasing Demand for Cell Therapies
5.2 Market Restraints
5.2.1 Disadvantages of Fluorescent Immunoassays
5.3 Market Opportunities
5.3.1 Extensive Usage in Cancer Diagnostics
5.4 Future Trends
5.4.1 Increase in Development of Fluorescent Dyes and Instruments
5.5 Impact Analysis
6. Fluorescent Immunoassay Market – North America Analysis
6.1 North America Fluorescent Immunoassay Marker Revenue Forecast and Analysis
7. North America Fluorescent Immunoassay Market Analysis – By Product Type
7.1 Overview
7.2 North America Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)
7.3 ELISA
7.3.1 Overview
7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.4 Rapid Lateral Flow Immunoassay
7.4.1 Overview
7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8. North America Fluorescent Immunoassay Market Analysis – By Application
8.1 Overview
8.2 North America Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.4 Oncology
8.4.1 Overview
8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9. North America Fluorescent Immunoassay Market Analysis – By End User
9.1 Overview
9.2 North America Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.5 Pharmaceutical & Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.6 Academic & Research Institutes
9.6.1 Overview
9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
10. North America Fluorescent Immunoassay Market Analysis – By Country
10.1 Overview
10.1.1 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 US: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.1.3 US: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 US: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.5 US: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.2 Canada: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.2.3 Canada: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 Canada: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.5 Canada: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.1.3 Mexico: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.1.3.3 Mexico: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 Mexico: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.5 Mexico: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BD
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Danaher
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 bioMerieux SA
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sysmex Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Siemens AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ortho Clinical Diagnostics Holdings plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Quidel Corporation
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms